Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. 3. Absorption, tissue distribution and metabolic fate.
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D002351:Carrageenan / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D004285:Dogs; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D000882:Haplorhini; D006321:Heart / Q000187:drug effects; D008297:Male; D009206:Myocardium / Q000378:metabolism; D010672:Phenytoin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D013057:Spectrum Analysis; D013450:Sulfones / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D013450:Sulfones; D010672:Phenytoin; D002351:Carrageenan